Loading...

VNRX VOLITIONRX LTD Management Changes 8-K Filing

VLTN

VNRX

VOLITIONRX LTD

(VNRX)

2024 8-K

Show Summary

Summary

Financial Results Announcement

Equity Offerings

Increase in authorized shares

Financial Statements

Share Sale Agreement

Stock Registration

Financial Results

Management Appointment

Director Appointment

Management Changes

Oncology Portfolio

Financial Results

Annual Meeting Approval and...

Earnings Reports

Financial Results and Busin...

Financing Round

Amendment to Stock Incentiv...

Agreement for Public Offering

External Links:

VolitionRx Limited appointed Dr. Ethel Rubin as a new director effective September 30, 2024, with a quarterly compensation of $10,840 and a grant of 15,000 restricted stock units vesting over three years.

AI Assistant

VOLITIONRX LTD

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.